课题基金 / 基金详情

Intrarenal Mechanisms of Ghrelin in Obesity-Hypertension

Intrarenal Mechanisms of Ghrelin in Obesity-Hypertension
生长素释放肽在肥胖-高血压中的肾内机制
批准号:
9337433
负责人:
SHETAL H PADIA
金额:
$35.55万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-08-25 至 2021-03-31

项目摘要

项目成果

SHETAL H PADIA的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结 体重超标导致的高血压风险高达65%,而血液的增加 高脂饮食(HFD)引起的血压(BP)在肾脏钠(Na+)显著降低之前 排泄量。只有以肾脏灌注量增加为代价,才能实现正常的Na+排泄 压力。随着时间的推移,肾脏需要血压升高才能继续排出正常的Na+ 装填。因此,调节肾脏钠离子流动的新途径的知识对我们在 优化肥胖高血压等重大公共卫生状况的治疗。最近,我们报道了, (1)直接肾输注Ghrelin,体内最有效的食欲刺激激素,激活GRs 集合管(CD)增加大鼠cAMP和ENaC依赖的Na+重吸收;(2)肾输注 单独使用GR拮抗剂(以阐明内源性Ghrelin的作用),可以诱导强烈的钠尿,表明 在正常情况下,循环中的Ghrelin的生理水平调节Na+重吸收;和(3)在 HFD,肾脏GR表达增加,肾内GR的药物阻断可防止HFD- 大鼠诱发性高血压。虽然这些数据建立了有关肾内GR的一些基本信息 Ghrelin的表达和功能目前尚不清楚肾内Ghrelin的产生及其信号转导途径 目的1)糖皮质激素受体介导的抗心钠素在高脂血症性高血压发病机制中的作用 (目标2)。在这一应用中,我们建议使用CD细胞进行体外研究,并在体内使用肥胖症的HFD模型。 目的:研究肾脏Ghrelin-GR系统的作用机制。分离肾脏糖皮质激素受体在 在慢性反应中,我们已经开发出一种小抑制性RNA(SiRNA),当长期注入到 肾脏,特异性地转导和敲除CD GR,同时保留GR在其他组织中的表达。 与基因敲除相比,这种方法的主要优点是它允许在没有基因敲除的情况下减少基因表达。 胚胎致死的危险,以及补偿性基因调控的风险较小。我们还将衡量 清醒状态下肾脏对GR表达的调控使分子释放到肾间质 使用一种新的微透析技术的大鼠,该技术允许分析更接近目标受体的介质和 更不容易发生循环退化。因此,在体外分子和体内之间流畅移动的能力 GR特有的功能反应是该方法的一个重要方面。
英文摘要
PROJECT SUMMARY Excess weight gain contributes up to 65% of the risk of primary hypertension, and the increase in blood pressure (BP) in response to high-fat diet (HFD) is preceded by significant reductions in renal sodium (Na+) excretory capacity. Normal Na+ excretion is then only achieved at the expense of elevated renal perfusion pressure. Over time, the kidneys reset to require an elevated BP in order to continue to excrete a normal Na+ load. The knowledge of novel pathways regulating renal Na+ flux is therefore crucial to our success in optimizing therapy for major public health conditions such as obesity- hypertension. Recently, we reported that (1) direct renal infusion of ghrelin, the most potent, appetite-stimulating hormone in the body, activates GRs in the collecting duct (CD) to increase cAMP and ENaC-dependent Na+ reabsorption in rats; (2) renal infusion of a GR antagonist alone (to elucidate the actions of endogenous ghrelin), induces a robust natriuresis, indicating that physiological levels of circulating ghrelin regulate Na+ reabsorption under normal conditions; and (3) in HFD, renal GR expression is increased, and pharmacological blockade of intrarenal GRs prevents HFD- induced hypertension in rats. While these data establish some basic information regarding intrarenal GR expression and function, nothing is known about intrarenal production of ghrelin and its signaling pathways (Aim 1) or the contribution of GR-mediated antinatriuresis to the pathogenesis of HFD-induced hypertension (Aim 2). In this application, we propose studies in vitro using CD cells & in vivo using a HFD model of obesity- hypertension to study the mechanisms of the renal ghrelin-GR system. To isolate the role of the renal GR in chronic responses, we have developed a small inhibitory RNA (siRNA), that when infused chronically into the kidney, specifically transfects & knocks down CD GRs, while preserving GR expression in the other tissues. The major advantage of this over gene knockout is that it permits reduction in the gene expression without dangers of embryonic lethality and with less risk of compensatory gene regulation. We will also measure molecules released into the renal interstitium in response to renal manipulations of GR expression in conscious rats utilizing a novel microdialysis technique which permits analysis of mediators closer to target receptors and less prone to circulatory degradation. Thus, the ability to move fluidly between in vitro molecular and in vivo functional responses specific to the GR is a major significant aspect of the approach.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Intrarenal Mechanisms of Ghrelin in Obesity-Hypertension
  • 批准号:
    9901519
  • 项目类别:
  • 资助金额:
    $35.55万
  • 财政年份:
    2016
  • 负责人:
    SHETAL H PADIA
  • 依托单位:
Natriuretic Mechanisms Uderlying Spontaneous Hypertension
  • 批准号:
    7876776
  • 项目类别:
  • 资助金额:
    $12.88万
  • 财政年份:
    2008
  • 负责人:
    SHETAL H PADIA
  • 依托单位:
Natriuretic Mechanisms Uderlying Spontaneous Hypertension
  • 批准号:
    8287201
  • 项目类别:
  • 资助金额:
    $12.88万
  • 财政年份:
    2008
  • 负责人:
    SHETAL H PADIA
  • 依托单位:
Natriuretic Mechanisms Uderlying Spontaneous Hypertension
  • 批准号:
    7689880
  • 项目类别:
  • 资助金额:
    $12.88万
  • 财政年份:
    2008
  • 负责人:
    SHETAL H PADIA
  • 依托单位:
海外基金